Notice of Abandonment

HERMIONE

Guangzhou Hemei Biotechnology Co., Ltd.

Official USPTO Notification: U.S. Trademark SN 90185929

From:	TMOfficialNotices@USPTO.GOV
Sent:	Tuesday, July 13, 2021 06:09 PM
To:	trademarks@branding-law.com ; admmaxhemp@163.com

Subject:	Official USPTO Notification: U.S. Trademark SN 90185929

OFFICIAL USPTO NOTICE OF ABANDONMENT

TRADEMARK APPLICATION ABANDONED AFTER INTER PARTES PROCEEDING

U.S. Application Serial No. 90185929

Mark: HERMIONE

Owner: Guangzhou Hemei Biotechnology Co., Ltd.

Docket/Reference No.

Issue Date: July 13, 2021

The application above is abandoned, based on a decision of the Trademark Trial and Appeal Board (TTAB) in an inter partes proceeding. 15 U.S.C. §1063.

To view TTAB records online, please visit the TTABVUE inquiry system.

For more information on the TTAB's policies and procedures, see the USPTO's webpage on the TTAB and the online version of the TBMP.

You can view this notice and other documents for this application online in the Trademark Status and Document Retrieval (TSDR) database.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.